Cargando…

New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells

The emergence of protein kinase D (PKD) as a potential therapeutic target for several diseases including cancer has triggered the search for potent, selective, and cell-permeable small molecule inhibitors. In this study, we describe the identification, in vitro characterization, structure-activity a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tandon, Manuj, Johnson, James, Li, Zhihong, Xu, Shuping, Wipf, Peter, Wang, Qiming Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781056/ https://www.ncbi.nlm.nih.gov/pubmed/24086585 http://dx.doi.org/10.1371/journal.pone.0075601

Ejemplares similares

A Targeted Library Screen Reveals a New Inhibitor Scaffold for Protein Kinase D
por: Tandon, Manuj, et al.
Publicado: (2012)

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
por: Makarov, Vadim A, et al.
Publicado: (2015)

SD-208, a Novel Protein Kinase D Inhibitor, Blocks Prostate Cancer Cell Proliferation and Tumor Growth In Vivo by Inducing G2/M Cell Cycle Arrest
por: Tandon, Manuj, et al.
Publicado: (2015)

Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)

Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis
por: McGillan, Paul, et al.
Publicado: (2021)

Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility
por: LaValle, Courtney R, et al.
Publicado: (2010)

Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells
por: Zhang, Liyong, et al.
Publicado: (2017)

Rapid Discovery and Structure–Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase
por: Fraser, Craig, et al.
Publicado: (2016)

Design, Synthesis and Antitumor Evaluation of Novel Pyrazolopyrimidines and Pyrazoloquinazolines
por: El-Naggar, Mohamed, et al.
Publicado: (2018)

Synthesis and Isomerization of Some Novel Pyrazolopyrimidine and Pyrazolotriazolopyrimidine Derivatives
por: Rashad, Aymn E., et al.
Publicado: (2014)

QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR
por: Chauhan, Jagat Singh, et al.
Publicado: (2014)

The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines
por: C. S. Pinheiro, Luiz, et al.
Publicado: (2019)

Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups
por: Alsaedi, Amani M. R., et al.
Publicado: (2019)

Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
por: Zhang, Liyong, et al.
Publicado: (2018)

α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer
por: Saito, Yohei, et al.
Publicado: (2021)

Development of Advanced Macrosphelides: Potent Anticancer Agents
por: Paek, Seung-Mann
Publicado: (2015)

Synthesis and Biological Evaluation of N- Pyrazolyl Derivatives and Pyrazolopyrimidine Bearing a Biologically Active Sulfonamide Moiety as Potential Antimicrobial Agent
por: Hafez, Hend N., et al.
Publicado: (2016)

N–N Bond-Forming Cyclization for the One-Pot Synthesis of N-Aryl[3,4-d]pyrazolopyrimidines
por: Evans, Lindsay E., et al.
Publicado: (2012)

A Novel Synthesis of Fused Uracils: Indenopyrimidopyridazines, Pyrimidopyridazines, and Pyrazolopyrimidines for Antimicrobial and Antitumor Evalution
por: El-Kalyoubi, Samar, et al.
Publicado: (2016)

Comprehensive Review on Betulin as a Potent Anticancer Agent
por: Król, Sylwia Katarzyna, et al.
Publicado: (2015)

Design, Synthesis, and Biological Evaluation of PKD Inhibitors
por: George, Kara M., et al.
Publicado: (2011)

Benzothiazole and Chromone Derivatives as Potential ATR Kinase Inhibitors and Anticancer Agents
por: Frasinyuk, Mykhaylo, et al.
Publicado: (2022)

Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents
por: Li, Bing-Hui, et al.
Publicado: (2021)

Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018)

Engineered Bacteriophage T7 as a Potent Anticancer Agent in vivo
por: Hwang, Yoon Jung, et al.
Publicado: (2020)

New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents
por: Dawood, Dina H., et al.
Publicado: (2021)

Anticancer/Antiviral Agent Akt Inhibitor-IV Massively Accumulates in Mitochondria and Potently Disrupts Cellular Bioenergetics
por: Meinig, J. Matthew, et al.
Publicado: (2014)

Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
por: Yang, Chunmin, et al.
Publicado: (2022)

Zinc Oxide Nanoparticles and Synthesized Pyrazolopyrimidine Alleviate Diabetic Effects in Rats Induced by Type II Diabetes
por: Gadoa, Zahraa Alaaeldein, et al.
Publicado: (2022)

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
por: Zhong, Hai-Jing, et al.
Publicado: (2015)

Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer
por: Kwon, Ahreum, et al.
Publicado: (2020)

1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents
por: Sirazhetdinova, Nafisa S., et al.
Publicado: (2020)

Biological Evaluation of Noscapine analogues as Potent and Microtubule-Targeted Anticancer Agents
por: Tomar, Vartika, et al.
Publicado: (2019)

2D and 3D-QSAR study on 4-anilinoquinozaline derivatives as potent apoptosis inducer and efficacious anticancer agent
por: Vyas, Vivek Kumar, et al.
Publicado: (2011)

Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
por: Martínez, Regina, et al.
Publicado: (2020)

Reliable Functionalization of 5,6‐Fused Bicyclic N‐Heterocycles Pyrazolopyrimidines and Imidazopyridazines via Zinc and Magnesium Organometallics
por: Kumar Rout, Saroj, et al.
Publicado: (2022)

Design, Green Synthesis and Tailoring of Vitamin E TPGS Augmented Niosomal Nano-Carrier of Pyrazolopyrimidines as Potential Anti-Liver and Breast Cancer Agents with Accentuated Oral Bioavailability
por: Anwer, Kurls E., et al.
Publicado: (2022)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
por: Yao, Yangyang, et al.
Publicado: (2017)

Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents
por: Tawfik, Haytham O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_la85rok554fo72qnropdpsip42